MARCELLA SORRELL: Open Payments
NPI 1780169219 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 88 payments from 22 companies in 2025. Trend: 2023 $2,299 · 2024 $2,005 · 2025 $1,811
Food & beverage: $1,711Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $399 |
| GlaxoSmithKline, LLC. | 16 | $216 |
| Grifols USA, LLC | 6 | $210 |
| Actelion Pharmaceuticals US, Inc. | 4 | $149 |
| HARMONY BIOSCIENCES LLC | 5 | $116 |
| Mallinckrodt Hospital Products Inc. | 3 | $76 |
| Amgen Inc. | 4 | $69 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $69 |
| Electromed, Inc. | 5 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
Products named: Prolastin-C Liquid, FASENRA, TEZSPIRE, OPSUMIT, TRELEGY ELLIPTA, WAKIX, NUCALA, DUPIXENT.
Industry payments across IA — which companies pay providers there.
